Integrum AB Stock: price and insider trades · Sweden

Integrum AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. 7 insiders have disclosed 12 filings since 18 October 2025.

On the market, 3 insiders bought (3 purchases totalling €52k) while 2 insiders sold (2 sales). The totals do not cover 3 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a purchase of €41k from Henric Carlsson, disclosed on 8 July 2026, or 0.18% of market capitalisation. Among those who bought: 2 board members and 1 chief executive.

Within a 30-day window, 1 purchase overlapped with buying by a second insider. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last purchase on record was published on 8 July 2026, which is 101 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19).

Across the 885 companies tracked on its exchange, the median is 7 filings; at 12 filings, this issuer sits above that mark. Our records for Integrum AB go back to 2025, with 3 purchases and 2 sales on the open market in total.

In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.